Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Global Market (the “Nasdaq Global Market”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq Global Market, nor, to the Company’s knowledge, is the SEC or the National Association of Securities Dealers, Inc. (the “NASD”) contemplating terminating such registration or listing. The Company and the Common Stock meet the criteria for continued listing and trading on the NASDAQ Global Market.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Solexa, Inc.), Securities Purchase Agreement (Illumina Inc)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act Act, and is listed on The Nasdaq Global NASDAQ National Market (the “Nasdaq Global "NASDAQ Stock Market”"), and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq Global NASDAQ Stock Market, nor, to nor has the Company’s knowledge, is Company received any notification that the SEC or the National Association of Securities Dealers, Inc. (the “NASD”) NASD is contemplating terminating such registration or listing. The To the best of the Company's knowledge, the Company and the Common Stock meet the criteria for continued listing and trading on the NASDAQ Global Stock Market.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Allos Therapeutics Inc), Securities Purchase Agreement (Warburg Pincus Private Equity Viii L P)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act Act, and is listed on The Nasdaq NASDAQ Global Market (the “Nasdaq Global NASDAQ Stock Market”), and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq Global NASDAQ Stock Market, nor, to nor has the Company’s knowledge, is Company received any notification that the SEC or the National Association of Securities Dealers, Inc. (the “NASD”) NASD is contemplating terminating such registration or listing. The To the best of the Company’s knowledge, the Company and the Common Stock meet the criteria for continued listing and trading on the NASDAQ Global Stock Market.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Inspire Pharmaceuticals Inc), Securities Purchase Agreement (Warburg Pincus Private Equity IX, L.P.)
Nasdaq Compliance. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act Act, and is listed on The Nasdaq Global NASDAQ National Market (the “Nasdaq Global NASDAQ Stock Market”), and trading in the Common Stock has not been suspended and the Company has taken no action designed to, or that is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing delisting the Common Stock from the Nasdaq Global NASDAQ Stock Market, nor, to nor has the Company’s knowledge, is Company received any notification that the SEC or the National Association of Securities Dealers, Inc. (the “NASD”) NASD is contemplating terminating such registration or listing. The To the best of the Company’s knowledge, the Company and the Common Stock meet the criteria for continued listing and trading on the NASDAQ Global Stock Market.
Appears in 1 contract
Samples: Securities Purchase Agreement (Allos Therapeutics Inc)
